Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10557	Companies
223269	Keywords
152306	Articles
118148	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 09/30/2024 at 23:00, 1 year 8 months ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights

Financial Results Biophytis Licensing Agreement Business Activities Obesity Program
REGULATED PRESS RELEASE

published on 09/30/2024 at 23:00, 1 year 8 months ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America

Financial Results Biophytis Latin America BIO101 OBA Program
BRIEF

published on 07/22/2024 at 08:17, 1 year 10 months ago

Biophytis Enters Asia Market with Strategic Partnerships

Biophytis Pharmaceutical Partnerships Market Expansion Asia
PRESS RELEASE

published on 07/22/2024 at 08:12, 1 year 10 months ago

Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
Biophytis signs partnership contracts with local agents in Asia to accelerate deployment of BIO101 drug candidate, targeting age-related diseases in key markets like Japan and China

Biophytis Partnership Asia Age-related Diseases BIO101
BRIEF

published on 07/22/2024 at 07:05, 1 year 10 months ago

Biophytis Signs Contracts with Local Agents in Asia

Biotechnology Pharmaceutical Partnerships Age-related Diseases Asia Market
REGULATED PRESS RELEASE

published on 07/22/2024 at 07:00, 1 year 10 months ago

Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
Biophytis implements partnership strategy in Asia with new contracts to advance drug candidate BIO101 in Japan, South Korea, China, and Southeast Asia

Biophytis Asia Contracts Partnership Strategy Drug Candidate BIO101
BRIEF

published on 07/11/2024 at 08:18, 1 year 11 months ago

Biophytis Obtains IND Approval from FDA for Phase 2 Obesity Study

Biophytis FDA Approval Phase 2 Clinical Trial BIO101 Obesity Study
PRESS RELEASE

published on 07/11/2024 at 08:13, 1 year 11 months ago

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis receives FDA IND approval for phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by renowned expert Marc-André Cornier

FDA Biophytis Obesity IND Approval OBA Study
BRIEF

published on 07/11/2024 at 07:06, 1 year 11 months ago

Biophytis Receives FDA IND Approval for Phase 2 Obesity Study

Biophytis FDA Approval Phase 2 Study BIO101 Obesity
REGULATED PRESS RELEASE

published on 07/11/2024 at 07:01, 1 year 11 months ago

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA

Biophytis FDA Approval Obesity Treatment BIO101 Phase 2 OBA Study

Accesswire

Published on 06/12/2026 at 00:00, 2 hours 33 minutes ago

Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
Published on 06/12/2026 at 00:00, 2 hours 33 minutes ago

UraniumX Closes Oversubscribed Flow-Through Private Placement
Published on 06/11/2026 at 22:55, 3 hours 38 minutes ago

Gamma Resources to Hold Annual General Meeting on August 12, 2026
Published on 06/11/2026 at 22:15, 4 hours 18 minutes ago

BlackBerry to Hold Annual Meeting of Shareholders on June 25, 2026
Published on 06/11/2026 at 22:05, 4 hours 28 minutes ago

First Canadian Graphite to Present at Planet MicroCap

View all ACCESSWIRE

EQS Group

Published on 06/12/2026 at 02:05, 28 minutes ago

Bedsure Brings Summer Sleep Solutions to Amazon Prime Day UK
Published on 06/11/2026 at 22:15, 4 hours 18 minutes ago

HHLA Annual General Meeting resolves transfer of class A shares to majority shareholder
Published on 06/11/2026 at 20:27, 6 hours 6 minutes ago

Turkiye Garanti Bankasi A.S.: Garanti BBVA 2025 TSRS-Aligned Sustainability Report
Published on 06/11/2026 at 19:50, 6 hours 43 minutes ago

GSMA Intelligence Finds Operators Could Be the Real Game-Changers of the 2026 World Cup
Published on 06/11/2026 at 19:30, 7 hours 3 minutes ago

EQS-Adhoc: Tirlán Co-operative Society Limited: PROPOSED SECONDARY PLACING & DIRECTED BUYBACK

Les Echos

Published on 06/11/2026 at 20:30, 6 hours 3 minutes ago

Mersen joins the SBF 120 index
Published on 06/11/2026 at 17:45, 8 hours 48 minutes ago

BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
Published on 06/11/2026 at 08:45, 17 hours 48 minutes ago

Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts
Published on 06/11/2026 at 08:30, 18 hours 3 minutes ago

Aéroports de Paris S.A - €600 million new bond issue
Published on 06/10/2026 at 18:29, 1 day 8 hours ago

ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026

View all LES ECHOS COMFI WIRE